Market Place
Sourcing Support
Stereotaxis Announces First Magic Procedures In The United States
22 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis To Release Q1 2026 Financial Results On May 12
21 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis Announces Definitive Agreement To Acquire Robocath
15 Apr 2026 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 Full Year Financial Results
09 Mar 2026 //
GLOBENEWSWIRE
Stereotaxis To Release 2025 Financial Results On March 9, 2026
12 Feb 2026 //
GLOBENEWSWIRE
Stereotaxis To Present At Piper Sandler Healthcare Conference
24 Nov 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 Third Quarter Financial Results
11 Nov 2025 //
GLOBENEWSWIRE
Stereotaxis To Release Q3 2025 Financial Results On Nov 11, 2025
21 Oct 2025 //
GLOBENEWSWIRE
Stereotaxis, Cardiofocus Partner To Advance Robotic Ablation
13 Oct 2025 //
GLOBENEWSWIRE
Stereotaxis to Present at Upcoming Investor Conferences
02 Sep 2025 //
GLOBENEWSWIRE
Stereotaxis Tech Showcased at Heart Rhythm Society`s HRX 2025
28 Aug 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 Second Quarter Financial Results
07 Aug 2025 //
GLOBENEWSWIRE
Stereotaxis to Report Q2 2025 Financial Results on August 7
23 Jul 2025 //
GLOBENEWSWIRE
Stereotaxis Announces $12.5M Offering of Common Stock
17 Jul 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2025 First Quarter Financial Results
12 May 2025 //
GLOBENEWSWIRE
Stereotaxis to Report Q1 2025 Financial Results on May 12, 2025
22 Apr 2025 //
GLOBENEWSWIRE
Stereotaxis to Present at 37th Annual Roth Conference
10 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 Full Year Financial Results
03 Mar 2025 //
GLOBENEWSWIRE
Stereotaxis to Report Q4 & Full Year Financial Results on March 3
03 Feb 2025 //
GLOBENEWSWIRE
Stereotaxis’ GenesisX To Debut At RSNA 2024 With Neusoft Medical
02 Dec 2024 //
GLOBENEWSWIRE
Stereotaxis to Attend Piper Sandler 36th Annual Health Conference
26 Nov 2024 //
GLOBENEWSWIRE
Stereotaxis Genesis Robotic System Gets Regulatory Approval in China
25 Nov 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 Q3 Financial Results
11 Nov 2024 //
GLOBENEWSWIRE
Stereotaxis Q3 2024 Financial Results on November 11
23 Oct 2024 //
GLOBENEWSWIRE
Stereotaxis Robotic Tech Featured at Heart Rhythm Society`s HRX Congress
03 Sep 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 Second Quarter Financial Results
12 Aug 2024 //
GLOBENEWSWIRE
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
22 Jul 2024 //
GLOBENEWSWIRE
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18 Jul 2024 //
GLOBENEWSWIRE
Stereotaxis Receives CE Mark Recertification Under EU`s MDR Regulatory Framework
24 May 2024 //
GLOBENEWSWIRE
First Robotic Heart Rhythm Treatment In Southern Italy
22 May 2024 //
GLOBENEWSWIRE
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
13 May 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2024 First Quarter Financial Results
13 May 2024 //
GLOBENEWSWIRE
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
22 Apr 2024 //
GLOBENEWSWIRE
Stereotaxis Reports 2023 Full Year Financial Results
04 Mar 2024 //
GLOBENEWSWIRE
Intermountain Health Extends Leadership in Heart Care
22 Feb 2024 //
GLOBENEWSWIRE
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results
20 Feb 2024 //
GLOBENEWSWIRE
Baptist Health Lexington Enhances 20-Year Leadership
28 Nov 2023 //
GLOBENEWSWIRE
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
20 Nov 2023 //
GLOBENEWSWIRE
Stereotaxis Reports 2023 Third Quarter Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Abbott and Stereotaxis Used in First Integrated Procedures in the United States
31 Oct 2023 //
GLOBENEWSWIRE
Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
17 Oct 2023 //
GLOBENEWSWIRE
Stereotaxis to be Featured during 7th Annual Meeting of the Society
04 Oct 2023 //
GLOBENEWSWIRE
Overland Park Regional Medical Center Becomes 1st U.S. Hospl with 2 Stereotaxis
30 Aug 2023 //
GLOBENEWSWIRE
Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology
16 Aug 2023 //
GLOBENEWSWIRE
Stereotaxis Reports 2023 Second Quarter Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Stereotaxis and Abbott Combine Technologies to Treat Arrhythmia Patients
18 Jul 2023 //
GLOBENEWSWIRE
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
17 Jul 2023 //
GLOBENEWSWIRE
Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application
15 Jun 2023 //
GLOBENEWSWIRE
Stereotaxis to Participate in 20th Annual Craig-Hallum Conference
25 May 2023 //
GLOBENEWSWIRE
Stereotaxis and Abbott Announce Global Collaboration
19 May 2023 //
GLOBENEWSWIRE
Stereotaxis Reports 2023 First Quarter Financial Results
09 May 2023 //
GLOBENEWSWIRE
Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023
18 Apr 2023 //
GLOBENEWSWIRE
Over 1,000 Cardiac Patients Treated with Genesis Robotic System
13 Apr 2023 //
GLOBENEWSWIRE
Stereotaxis Reports 2022 Full Year Financial Results
03 Mar 2023 //
GLOBENEWSWIRE
Stereotaxis to Present at Cowen 43rd Annual Health Care Conference
21 Feb 2023 //
GLOBENEWSWIRE
Stereotaxis to Report Fourth Quarter and Full Year 2022 Financial Results
02 Feb 2023 //
GLOBENEWSWIRE
Stereotaxis to Participate in Piper Sandler 34th Annual Healthcare Conference
28 Nov 2022 //
GLOBENEWSWIRE
Stereotaxis to Report Third Quarter Financial Results on November 10, 2022
20 Oct 2022 //
GLOBENEWSWIRE
International Meeting of the Society for Cardiac Robotic Navigation
29 Sep 2022 //
GLOBENEWSWIRE
